HUT70766A - Pharmaceutical compositions containing immune stimulants for preventing bacterial infections - Google Patents

Pharmaceutical compositions containing immune stimulants for preventing bacterial infections

Info

Publication number
HUT70766A
HUT70766A HU9401775A HU9401775A HUT70766A HU T70766 A HUT70766 A HU T70766A HU 9401775 A HU9401775 A HU 9401775A HU 9401775 A HU9401775 A HU 9401775A HU T70766 A HUT70766 A HU T70766A
Authority
HU
Hungary
Prior art keywords
pharmaceutical compositions
compositions containing
bacterial infections
preventing bacterial
containing immune
Prior art date
Application number
HU9401775A
Other languages
Hungarian (hu)
Other versions
HU9401775D0 (en
Inventor
Peter C Canning
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HU9401775D0 publication Critical patent/HU9401775D0/en
Publication of HUT70766A publication Critical patent/HUT70766A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU9401775A 1993-06-15 1994-06-14 Pharmaceutical compositions containing immune stimulants for preventing bacterial infections HUT70766A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7784693A 1993-06-15 1993-06-15
US12210893A 1993-09-16 1993-09-16

Publications (2)

Publication Number Publication Date
HU9401775D0 HU9401775D0 (en) 1994-09-28
HUT70766A true HUT70766A (en) 1995-10-30

Family

ID=26759749

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9401775A HUT70766A (en) 1993-06-15 1994-06-14 Pharmaceutical compositions containing immune stimulants for preventing bacterial infections

Country Status (7)

Country Link
EP (1) EP0703782A1 (en)
JP (1) JPH08506353A (en)
AU (1) AU6436394A (en)
CA (1) CA2165344A1 (en)
HU (1) HUT70766A (en)
IL (1) IL109953A0 (en)
WO (1) WO1994028898A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011080132A2 (en) 2009-12-17 2011-07-07 Katholieke Universiteit Leuven, K.U. Leuven R&D Compounds, compositions and methods for controlling biofilms
AR081626A1 (en) 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
CN110237075A (en) * 2019-06-25 2019-09-17 华中农业大学 A kind of purposes of Danofloxacin in treatment haemophilus parasuis drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
US4636498A (en) * 1984-10-11 1987-01-13 Pfizer Inc. Formulation of antiinflammatory drugs
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis

Also Published As

Publication number Publication date
HU9401775D0 (en) 1994-09-28
CA2165344A1 (en) 1994-12-22
JPH08506353A (en) 1996-07-09
IL109953A0 (en) 1994-10-07
AU6436394A (en) 1995-01-03
EP0703782A1 (en) 1996-04-03
WO1994028898A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
GB2251791B (en) Pharmaceutical compositions containing benzenesulphonamides
HU9303143D0 (en) Pharmaceutical compositions
ZA922834B (en) Pharmaceutical compositions
IL110201A0 (en) Novel pharmaceutical compositions
GB9200253D0 (en) Pharmaceutical compositions
HUT70766A (en) Pharmaceutical compositions containing immune stimulants for preventing bacterial infections
GB9111314D0 (en) Pharmaceutical compositions
GB9023023D0 (en) Pharmaceutical compositions
GB9214757D0 (en) Pharmaceutical compositions
AU2537992A (en) Pharmaceutical compositions
GB9026080D0 (en) Pharmaceutical compositions
GB9003185D0 (en) Pharmaceutical compositions
GB9121631D0 (en) Pharmaceutical compositions
GB9115156D0 (en) Pharmaceutical compositions
GB9200414D0 (en) Pharmaceutical compositions
GB9115169D0 (en) Pharmaceutical compositions
AU9016891A (en) Pharmaceutical compositions
GB9108643D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions
GB9123423D0 (en) Pharmaceutical compositions
GB9121989D0 (en) Pharmaceutical compositions
GB9121291D0 (en) Pharmaceutical compositions
GB9113805D0 (en) Pharmaceutical compositions
GB9100464D0 (en) Pharmaceutical compositions
GB9110884D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
DFD9 Temporary protection cancelled due to non-payment of fee